Literature DB >> 17379832

Dual channel optical tomographic imaging of leukocyte recruitment and protease activity in the healing myocardial infarct.

Matthias Nahrendorf1, David E Sosnovik, Peter Waterman, Filip K Swirski, Ashvin N Pande, Elena Aikawa, Jose-Luiz Figueiredo, Mikael J Pittet, Ralph Weissleder.   

Abstract

Inflammatory responses after myocardial infarction profoundly impact tissue repair. Yet, efficient tools to serially and noninvasively assess cellular and molecular functions in postinfarct inflammation are lacking. Here we use multichannel fluorescent molecular tomography (FMT) for spatiotemporal resolution of phagocytic and proteolytic activities mediated by macrophages and neutrophils in murine infarcts. We performed FMT imaging to compare the course of efficient and impaired healing in wild-type and FXIII-/- mice, respectively. Mice subjected to coronary ligation received simultaneous injections with Prosense-680, an activatable fluorescence sensor reporting on cathepsin activity, and CLIO-VT750, a magneto-fluorescent nanoparticle for imaging of phagocyte recruitment. On FMT, Prosense-680 infarct signal was 19-fold higher than background (P<0.05). Protease activity was higher in the infarcted lateral wall than in the remote, uninjured septum on ex vivo fluorescence reflectance imaging (contrast to noise ratio 118+/-24). CLIO-VT750 FMT signal coregistered with contrast enhancement in the hypokinetic infarct on MRI. Microscopic fluorescence signal colocalized with immunoreactive staining for cathepsin, macrophages and neutrophils. Flow cytometry of digested infarcts revealed monocytes/macrophages and neutrophils as the source of the fluorescence signal. Phagocytic activity peaked on day 6, and proteolytic activity peaked on day 4 after myocardial infarction. FMT detected impaired recruitment of phagocytes and protease activity in FXIII-/- mice (P<0.05). FMT is a promising noninvasive molecular imaging approach to characterize infarct healing. Spectrally resolved imaging agents allow for simultaneous assesment of key processes of in vivo cellular functions. Specifically, we show that in vivo FMT detects impaired healing in FXIII-/- mice.

Entities:  

Mesh:

Substances:

Year:  2007        PMID: 17379832     DOI: 10.1161/01.RES.0000265064.46075.31

Source DB:  PubMed          Journal:  Circ Res        ISSN: 0009-7330            Impact factor:   17.367


  84 in total

Review 1.  In vivo imaging in cancer.

Authors:  John Condeelis; Ralph Weissleder
Journal:  Cold Spring Harb Perspect Biol       Date:  2010-09-22       Impact factor: 10.005

Review 2.  Cardiovascular molecular imaging: focus on clinical translation.

Authors:  Ian Y Chen; Joseph C Wu
Journal:  Circulation       Date:  2011-02-01       Impact factor: 29.690

Review 3.  MR-optical imaging of cardiovascular molecular targets.

Authors:  Matthias Nahrendorf; David E Sosnovik; Ralph Weissleder
Journal:  Basic Res Cardiol       Date:  2008-03       Impact factor: 17.165

Review 4.  Magnetic nanoparticles for MR imaging: agents, techniques and cardiovascular applications.

Authors:  David E Sosnovik; Matthias Nahrendorf; Ralph Weissleder
Journal:  Basic Res Cardiol       Date:  2008-03       Impact factor: 17.165

Review 5.  Molecular imaging in cardiovascular magnetic resonance imaging: current perspective and future potential.

Authors:  David E Sosnovik
Journal:  Top Magn Reson Imaging       Date:  2008-02

6.  In vivo fluorescence lifetime detection of an activatable probe in infarcted myocardium.

Authors:  Craig J Goergen; Howard H Chen; Alexei Bogdanov; David E Sosnovik; Anand T N Kumar
Journal:  J Biomed Opt       Date:  2012-05       Impact factor: 3.170

7.  High-resolution optical mapping of inflammatory macrophages following endovascular arterial injury.

Authors:  Amit Saxena; Chase W Kessinger; Brian Thompson; Jason R McCarthy; Yoshiko Iwamoto; Charles P Lin; Farouc A Jaffer
Journal:  Mol Imaging Biol       Date:  2013-06       Impact factor: 3.488

8.  Dual in vivo quantification of integrin-targeted and protease-activated agents in cancer using fluorescence molecular tomography (FMT).

Authors:  Sylvie Kossodo; Maureen Pickarski; Shu-An Lin; Alexa Gleason; Renee Gaspar; Chiara Buono; Guojie Ho; Agnieszka Blusztajn; Garry Cuneo; Jun Zhang; Jayme Jensen; Richard Hargreaves; Paul Coleman; George Hartman; Milind Rajopadhye; Le Thi Duong; Cyrille Sur; Wael Yared; Jeffrey Peterson; Bohumil Bednar
Journal:  Mol Imaging Biol       Date:  2009-12-04       Impact factor: 3.488

9.  Hybrid in vivo FMT-CT imaging of protease activity in atherosclerosis with customized nanosensors.

Authors:  Matthias Nahrendorf; Peter Waterman; Greg Thurber; Kevin Groves; Milind Rajopadhye; Peter Panizzi; Brett Marinelli; Elena Aikawa; Mikael J Pittet; Filip K Swirski; Ralph Weissleder
Journal:  Arterioscler Thromb Vasc Biol       Date:  2009-07-16       Impact factor: 8.311

10.  Fluorescence tomography of rapamycin-induced autophagy and cardioprotection in vivo.

Authors:  Howard H Chen; Choukri Mekkaoui; Hoonsung Cho; Soeun Ngoy; Brett Marinelli; Peter Waterman; Matthias Nahrendorf; Ronglih Liao; Lee Josephson; David E Sosnovik
Journal:  Circ Cardiovasc Imaging       Date:  2013-03-28       Impact factor: 7.792

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.